Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Atom- and step-economical preparation of reduced Knoevenagel adducts using CO as a deoxygenative agent.

Organic letters

Kolesnikov PN, Usanov DL, Barablina EA, Maleev VI, Chusov D.
PMID: 25225971
Org Lett. 2014 Oct 03;16(19):5068-71. doi: 10.1021/ol502424t. Epub 2014 Sep 16.

A highly efficient one-step Rh-catalyzed preparation of reduced Knoevenagel adducts of various aldehydes and ketones with active methylene compounds has been developed. The protocol does not require an external hydrogen source and employs carbon monoxide as a deoxygenative agent....

Cite
Kolesnikov PN, Usanov DL, Barablina EA, et al. Atom- and step-economical preparation of reduced Knoevenagel adducts using CO as a deoxygenative agent. Org Lett. 2014;16(19):5068-71doi: 10.1021/ol502424t.
Kolesnikov, P. N., Usanov, D. L., Barablina, E. A., Maleev, V. I., & Chusov, D. (2014). Atom- and step-economical preparation of reduced Knoevenagel adducts using CO as a deoxygenative agent. Organic letters, 16(19), 5068-71. https://doi.org/10.1021/ol502424t
Kolesnikov, Pavel N, et al. "Atom- and step-economical preparation of reduced Knoevenagel adducts using CO as a deoxygenative agent." Organic letters vol. 16,19 (2014): 5068-71. doi: https://doi.org/10.1021/ol502424t
Kolesnikov PN, Usanov DL, Barablina EA, Maleev VI, Chusov D. Atom- and step-economical preparation of reduced Knoevenagel adducts using CO as a deoxygenative agent. Org Lett. 2014 Oct 03;16(19):5068-71. doi: 10.1021/ol502424t. Epub 2014 Sep 16. PMID: 25225971.
Copy Download .nbib Format: NLM
[New Ideas in the Treatment of Chronic Cardiac Failure. Inotropic Stimulation of the Heart in the Era of ECA Inhibitors and beta-adrenoblockers].

Kardiologiia

Mareev VI.
PMID: 12469097
Kardiologiia. 2001;41(12):4-13.

No abstract available.

Cite
Mareev VI. Novye idei v lechenii khronicheskoĭ serdechnoĭ nedostatochnosti. Inotropnaia stimuliaciia serdtsa v éru ingibitorov angiotenzinprevrashchaiushchego fermenta i beta-adrenoblokatorov. [New Ideas in the Treatment of Chronic Cardiac Failure. Inotropic Stimulation of the Heart in the Era of ECA Inhibitors and beta-adrenoblockers]. Kardiologiia. 2001;41(12):4-13
Mareev, V. I. (2001). Novye idei v lechenii khronicheskoĭ serdechnoĭ nedostatochnosti. Inotropnaia stimuliaciia serdtsa v éru ingibitorov angiotenzinprevrashchaiushchego fermenta i beta-adrenoblokatorov. [New Ideas in the Treatment of Chronic Cardiac Failure. Inotropic Stimulation of the Heart in the Era of ECA Inhibitors and beta-adrenoblockers]. Kardiologiia, 41(12), 4-13.
Mareev, V. Iu.. "Novye idei v lechenii khronicheskoĭ serdechnoĭ nedostatochnosti. Inotropnaia stimuliaciia serdtsa v éru ingibitorov angiotenzinprevrashchaiushchego fermenta i beta-adrenoblokatorov." [New Ideas in the Treatment of Chronic Cardiac Failure. Inotropic Stimulation of the Heart in the Era of ECA Inhibitors and beta-adrenoblockers]. Kardiologiia vol. 41,12 (2001): 4-13.
Mareev VI. Novye idei v lechenii khronicheskoĭ serdechnoĭ nedostatochnosti. Inotropnaia stimuliaciia serdtsa v éru ingibitorov angiotenzinprevrashchaiushchego fermenta i beta-adrenoblokatorov. [New Ideas in the Treatment of Chronic Cardiac Failure. Inotropic Stimulation of the Heart in the Era of ECA Inhibitors and beta-adrenoblockers]. Kardiologiia. 2001;41(12):4-13. Russian. PMID: 12469097.
Copy Download .nbib Format: NLM
A general asymmetric synthesis of artificial aliphatic and perfluoroalkylated α-amino acids by Luche's cross-electrophile coupling reaction.

Organic & biomolecular chemistry

Gugkaeva ZT, Smol'yakov AF, Maleev VI, Larionov VA.
PMID: 34042928
Org Biomol Chem. 2021 Jun 28;19(24):5327-5332. doi: 10.1039/d1ob00805f. Epub 2021 May 27.

Aliphatic artificial α-amino acids (α-AAs) have attracted great interest in biochemistry and pharmacy. In this context, we developed a promising practical protocol for the asymmetric synthesis of these α-AAs through the selective and efficient intermolecular cross-electrophile coupling of Belokon's...

Cite
Gugkaeva ZT, Smol'yakov AF, Maleev VI, et al. A general asymmetric synthesis of artificial aliphatic and perfluoroalkylated α-amino acids by Luche's cross-electrophile coupling reaction. Org Biomol Chem. 2021;19(24):5327-5332doi: 10.1039/d1ob00805f.
Gugkaeva, Z. T., Smol'yakov, A. F., Maleev, V. I., & Larionov, V. A. (2021). A general asymmetric synthesis of artificial aliphatic and perfluoroalkylated α-amino acids by Luche's cross-electrophile coupling reaction. Organic & biomolecular chemistry, 19(24), 5327-5332. https://doi.org/10.1039/d1ob00805f
Gugkaeva, Zalina T, et al. "A general asymmetric synthesis of artificial aliphatic and perfluoroalkylated α-amino acids by Luche's cross-electrophile coupling reaction." Organic & biomolecular chemistry vol. 19,24 (2021): 5327-5332. doi: https://doi.org/10.1039/d1ob00805f
Gugkaeva ZT, Smol'yakov AF, Maleev VI, Larionov VA. A general asymmetric synthesis of artificial aliphatic and perfluoroalkylated α-amino acids by Luche's cross-electrophile coupling reaction. Org Biomol Chem. 2021 Jun 28;19(24):5327-5332. doi: 10.1039/d1ob00805f. Epub 2021 May 27. PMID: 34042928.
Copy Download .nbib Format: NLM
Robust bifunctional aluminium-salen catalysts for the preparation of cyclic carbonates from carbon dioxide and epoxides.

Beilstein journal of organic chemistry

Rulev YA, Gugkaeva Z, Maleev VI, North M, Belokon YN.
PMID: 26664580
Beilstein J Org Chem. 2015 Sep 11;11:1614-23. doi: 10.3762/bjoc.11.176. eCollection 2015.

Two new one-component aluminium-based catalysts for the reaction between epoxides and carbon dioxide have been prepared. The catalysts are composed of aluminium-salen chloride complexes with trialkylammonium groups directly attached to the aromatic rings of the salen ligand. With terminal...

Cite
Rulev YA, Gugkaeva Z, Maleev VI, et al. Robust bifunctional aluminium-salen catalysts for the preparation of cyclic carbonates from carbon dioxide and epoxides. Beilstein J Org Chem. 2015;11:1614-23doi: 10.3762/bjoc.11.176.
Rulev, Y. A., Gugkaeva, Z., Maleev, V. I., North, M., & Belokon, Y. N. (2015). Robust bifunctional aluminium-salen catalysts for the preparation of cyclic carbonates from carbon dioxide and epoxides. Beilstein journal of organic chemistry, 111614-23. https://doi.org/10.3762/bjoc.11.176
Rulev, Yuri A, et al. "Robust bifunctional aluminium-salen catalysts for the preparation of cyclic carbonates from carbon dioxide and epoxides." Beilstein journal of organic chemistry vol. 11 (2015): 1614-23. doi: https://doi.org/10.3762/bjoc.11.176
Rulev YA, Gugkaeva Z, Maleev VI, North M, Belokon YN. Robust bifunctional aluminium-salen catalysts for the preparation of cyclic carbonates from carbon dioxide and epoxides. Beilstein J Org Chem. 2015 Sep 11;11:1614-23. doi: 10.3762/bjoc.11.176. eCollection 2015. PMID: 26664580; PMCID: PMC4660930.
Copy Download .nbib Format: NLM
Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.

ESC heart failure

Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh TA, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD.
PMID: 28834668
ESC Heart Fail. 2014 Sep;1(1):52-58. doi: 10.1002/ehf2.12006.

BACKGROUND: Iron deficiency (ID) is a common co-morbidity associated with chronic heart failure (CHF), which has unfavourable clinical and prognostic consequences. In Ferinject Assessment in Patients with IRon Deficiency and Chronic Heart Failure (FAIR-HF), the treatment with i.v. ferric...

Cite
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency. ESC Heart Fail. 2014;1(1):52-58doi: 10.1002/ehf2.12006.
Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T. A., Parkhomenko, A., Tavazzi, L., Levesque, V., Mori, C., Roubert, B., Filippatos, G., Ruschitzka, F., & Anker, S. D. (2014). Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency. ESC heart failure, 1(1), 52-58. https://doi.org/10.1002/ehf2.12006
Ponikowski, Piotr, et al. "Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency." ESC heart failure vol. 1,1 (2014): 52-58. doi: https://doi.org/10.1002/ehf2.12006
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh TA, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency. ESC Heart Fail. 2014 Sep;1(1):52-58. doi: 10.1002/ehf2.12006. PMID: 28834668.
Copy Download .nbib Format: NLM
Polycyanoacrylate porous material for bone tissue substitution.

Journal of materials chemistry. B

Rustamov IR, Dyatlov VA, Grebeneva TA, Dyatlov AV, Zaitsev VV, Maleev VI.
PMID: 32261569
J Mater Chem B. 2014 Jul 21;2(27):4310-4317. doi: 10.1039/c4tb00554f. Epub 2014 Jun 06.

A proof of concept study has been conducted for the design of a porous biodegradable material containing nanocapsules and two actives with independent release-bimodal drug-eluting implants. Completely safe synthetic material free from risk of prion and virus contamination was...

Cite
Rustamov IR, Dyatlov VA, Grebeneva TA, et al. Polycyanoacrylate porous material for bone tissue substitution. J Mater Chem B. 2014;2(27):4310-4317doi: 10.1039/c4tb00554f.
Rustamov, I. R., Dyatlov, V. A., Grebeneva, T. A., Dyatlov, A. V., Zaitsev, V. V., & Maleev, V. I. (2014). Polycyanoacrylate porous material for bone tissue substitution. Journal of materials chemistry. B, 2(27), 4310-4317. https://doi.org/10.1039/c4tb00554f
Rustamov, I R, et al. "Polycyanoacrylate porous material for bone tissue substitution." Journal of materials chemistry. B vol. 2,27 (2014): 4310-4317. doi: https://doi.org/10.1039/c4tb00554f
Rustamov IR, Dyatlov VA, Grebeneva TA, Dyatlov AV, Zaitsev VV, Maleev VI. Polycyanoacrylate porous material for bone tissue substitution. J Mater Chem B. 2014 Jul 21;2(27):4310-4317. doi: 10.1039/c4tb00554f. Epub 2014 Jun 06. PMID: 32261569.
Copy Download .nbib Format: NLM
Ruthenium-catalyzed reductive amination without an external hydrogen source.

Organic letters

Kolesnikov PN, Yagafarov NZ, Usanov DL, Maleev VI, Chusov D, ÜLGER BB, Çepni S.
PMID: 25549756
Org Lett. 2015 Jan 16;17(2):173-5. doi: 10.1021/ol503595m. Epub 2014 Dec 31.

A ruthenium-catalyzed reductive amination without an external hydrogen source has been developed using carbon monoxide as the reductant and ruthenium(III) chloride (0.008-2 mol %) as the catalyst. The method was applied to the synthesis of antianxiety agent ladasten.

Cite
Kolesnikov PN, Yagafarov NZ, Usanov DL, et al. Ruthenium-catalyzed reductive amination without an external hydrogen source. Org Lett. 2014;17(2):173-5doi: 10.1021/ol503595m.
Kolesnikov, P. N., Yagafarov, N. Z., Usanov, D. L., Maleev, V. I., Chusov, D., ÜLGER, B. B., & Çepni, S. (2015). Ruthenium-catalyzed reductive amination without an external hydrogen source. Organic letters, 17(2), 173-5. https://doi.org/10.1021/ol503595m
Kolesnikov, Pavel N, et al. "Ruthenium-catalyzed reductive amination without an external hydrogen source." Organic letters vol. 17,2 (2015): 173-5. doi: https://doi.org/10.1021/ol503595m
Kolesnikov PN, Yagafarov NZ, Usanov DL, Maleev VI, Chusov D, ÜLGER BB, Çepni S. Ruthenium-catalyzed reductive amination without an external hydrogen source. Org Lett. 2015 Jan 16;17(2):173-5. doi: 10.1021/ol503595m. Epub 2014 Dec 31. PMID: 25549756.
Copy Download .nbib Format: NLM
Interaction of a trinuclear copper(i) pyrazolate with alkynes and carbon-carbon triple bond activation.

Chemical communications (Cambridge, England)

Titov AA, Larionov VA, Smol'yakov AF, Godovikova MI, Titova EM, Maleev VI, Shubina ES.
PMID: 30411109
Chem Commun (Camb). 2019 Jan 02;55(3):290-293. doi: 10.1039/c8cc08592g.

The trinuclear copper(i) pyrazolate {[3,5-(CF3)2Pz]Cu}3 forms η2-copper/alkyne triple bond coordinated structures in the presence of acetylenes. There is no coordination of copper atoms to the phenyl ring of phenylacetylene and copper(i) acetylide formation during the interaction. It was observed...

Cite
Titov AA, Larionov VA, Smol'yakov AF, et al. Interaction of a trinuclear copper(i) pyrazolate with alkynes and carbon-carbon triple bond activation. Chem Commun (Camb). 2019;55(3):290-293doi: 10.1039/c8cc08592g.
Titov, A. A., Larionov, V. A., Smol'yakov, A. F., Godovikova, M. I., Titova, E. M., Maleev, V. I., & Shubina, E. S. (2019). Interaction of a trinuclear copper(i) pyrazolate with alkynes and carbon-carbon triple bond activation. Chemical communications (Cambridge, England), 55(3), 290-293. https://doi.org/10.1039/c8cc08592g
Titov, Aleksei A, et al. "Interaction of a trinuclear copper(i) pyrazolate with alkynes and carbon-carbon triple bond activation." Chemical communications (Cambridge, England) vol. 55,3 (2019): 290-293. doi: https://doi.org/10.1039/c8cc08592g
Titov AA, Larionov VA, Smol'yakov AF, Godovikova MI, Titova EM, Maleev VI, Shubina ES. Interaction of a trinuclear copper(i) pyrazolate with alkynes and carbon-carbon triple bond activation. Chem Commun (Camb). 2019 Jan 02;55(3):290-293. doi: 10.1039/c8cc08592g. PMID: 30411109.
Copy Download .nbib Format: NLM
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT.

European stroke journal

Abdul-Rahim AH, Docherty KF, Skali H, Køber L, Dickstein K, Maggioni AP, Mareev V, Zannad F, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD, Lees KR, McMurray JJ.
PMID: 31008270
Eur Stroke J. 2016 Jun;1(2):93-100. doi: 10.1177/2396987316646025. Epub 2016 May 09.

INTRODUCTION: Concern has been raised about a possible increase in risk of stroke in patients with diabetes treated with the combination of the renin-inhibitor aliskiren and an angiotensin converting enzyme inhibitor or angiotensin receptor blocker. We compared the rate...

Cite
Abdul-Rahim AH, Docherty KF, Skali H, et al. Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. Eur Stroke J. 2016;1(2):93-100doi: 10.1177/2396987316646025.
Abdul-Rahim, A. H., Docherty, K. F., Skali, H., Køber, L., Dickstein, K., Maggioni, A. P., Mareev, V., Zannad, F., Velazquez, E. J., Califf, R. M., Pfeffer, M. A., Solomon, S. D., Lees, K. R., & McMurray, J. J. (2016). Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. European stroke journal, 1(2), 93-100. https://doi.org/10.1177/2396987316646025
Abdul-Rahim, Azmil H, et al. "Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT." European stroke journal vol. 1,2 (2016): 93-100. doi: https://doi.org/10.1177/2396987316646025
Abdul-Rahim AH, Docherty KF, Skali H, Køber L, Dickstein K, Maggioni AP, Mareev V, Zannad F, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD, Lees KR, McMurray JJ. Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT. Eur Stroke J. 2016 Jun;1(2):93-100. doi: 10.1177/2396987316646025. Epub 2016 May 09. PMID: 31008270; PMCID: PMC6301225.
Copy Download .nbib Format: NLM
[Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity].

Urologiia (Moscow, Russia : 1999)

Kamalov AA, Mareev VY, Orlova IA, Ohobotov DA, Mareev YV, Begrambekova YL, Pavlova ZS, Plisyk AG, Samokhodskaya LM, Mershina EA, Tretyakov AA, Nesterova OY, Shurygina AS.
PMID: 34967512
Urologiia. 2021 Dec;(6):85-99.

OBJECTIVE: Analysis of androgen status in men hospitalized with a moderate COVID-19 and its relationship with the severity of the disease.MATERIALS AND METHODS: The study included 152 males with a confirmed diagnosis of COVID-19 based on the results of...

Cite
Kamalov AA, Mareev VY, Orlova IA, et al. [Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity]. Urologiia. 2021;(6):85-99
Kamalov, A. A., Mareev, V. Y., Orlova, I. A., Ohobotov, D. A., Mareev, Y. V., Begrambekova, Y. L., Pavlova, Z. S., Plisyk, A. G., Samokhodskaya, L. M., Mershina, E. A., Tretyakov, A. A., Nesterova, O. Y., & Shurygina, A. S. (2021). [Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity]. Urologiia (Moscow, Russia : 1999), (6), 85-99.
Kamalov, A A, et al. "[Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity]." Urologiia (Moscow, Russia : 1999) vol. ,6 (2021): 85-99.
Kamalov AA, Mareev VY, Orlova IA, Ohobotov DA, Mareev YV, Begrambekova YL, Pavlova ZS, Plisyk AG, Samokhodskaya LM, Mershina EA, Tretyakov AA, Nesterova OY, Shurygina AS. [Features of a new corOnavirUs infection course and optioNs therapy DEpending on the andRogenic status (FOUNDER): androgenic status in men with COVID-19 and its relationship with the disease severity]. Urologiia. 2021 Dec;(6):85-99. Russian. PMID: 34967512.
Copy Download .nbib Format: NLM
[Focus ultrasound for cardiology practice. Russian consensus document].

Kardiologiia

Mareev YV, Dzhioeva ON, Zorya OT, Pisaryuk AS, Verbilo SL, Skaletsky KV, Ionin VA, Drapkina OM, Alekhin MN, Saidova MA, Safarova AF, Garganeeva AA, Boshchenko AA, Ovchinnikov AG, Chernov MY, Ageev FT, Vasyuk YA, Kobalava ZD, Nosikov AV, Safonov DV, Khudorozhkova ED, Belenkov YN, Mitkov VV, Mitkova MD, Matskeplishvili ST, Mareev VY.
PMID: 34882074
Kardiologiia. 2021 Nov 30;61(11):4-23. doi: 10.18087/cardio.2021.11.n1812.

This document is a consensus document of Russian Specialists in Heart Failure, Russian Society of Cardiology, Russian Association of Specialists in Ultrasound Diagnostics in Medicine and Russian Society for the Prevention of Noncommunicable Diseases. In the document a definition...

Cite
Mareev YV, Dzhioeva ON, Zorya OT, et al. [Focus ultrasound for cardiology practice. Russian consensus document]. Kardiologiia. 2021;61(11):4-23doi: 10.18087/cardio.2021.11.n1812.
Mareev, Y. V., Dzhioeva, O. N., Zorya, O. T., Pisaryuk, A. S., Verbilo, S. L., Skaletsky, K. V., Ionin, V. A., Drapkina, O. M., Alekhin, M. N., Saidova, M. A., Safarova, A. F., Garganeeva, A. A., Boshchenko, A. A., Ovchinnikov, A. G., Chernov, M. Y., Ageev, F. T., Vasyuk, Y. A., Kobalava, Z. D., Nosikov, A. V., Safonov, D. V., Khudorozhkova, E. D., Belenkov, Y. N., Mitkov, V. V., Mitkova, M. D., Matskeplishvili, S. T., & Mareev, V. Y. (2021). [Focus ultrasound for cardiology practice. Russian consensus document]. Kardiologiia, 61(11), 4-23. https://doi.org/10.18087/cardio.2021.11.n1812
Mareev, Yu V, et al. "[Focus ultrasound for cardiology practice. Russian consensus document]." Kardiologiia vol. 61,11 (2021): 4-23. doi: https://doi.org/10.18087/cardio.2021.11.n1812
Mareev YV, Dzhioeva ON, Zorya OT, Pisaryuk AS, Verbilo SL, Skaletsky KV, Ionin VA, Drapkina OM, Alekhin MN, Saidova MA, Safarova AF, Garganeeva AA, Boshchenko AA, Ovchinnikov AG, Chernov MY, Ageev FT, Vasyuk YA, Kobalava ZD, Nosikov AV, Safonov DV, Khudorozhkova ED, Belenkov YN, Mitkov VV, Mitkova MD, Matskeplishvili ST, Mareev VY. [Focus ultrasound for cardiology practice. Russian consensus document]. Kardiologiia. 2021 Nov 30;61(11):4-23. doi: 10.18087/cardio.2021.11.n1812. Russian. PMID: 34882074.
Copy Download .nbib Format: NLM
[Various urgent problems of refractory cardiac insufficiency].

Terapevticheskii arkhiv

Mukharliamov NM, Mareev VIu.
PMID: 741371
Ter Arkh. 1978;50(12):3-10.

No abstract available.

Cite
Mukharliamov NM, Mareev VIu. Nekotorye aktual'nye voprosy refrakternoĭ serdechnoĭ nedostatochnosti. [Various urgent problems of refractory cardiac insufficiency]. Ter Arkh. 1978;50(12):3-10
Mukharliamov, N. M., & Mareev, V. I. u. (1978). Nekotorye aktual'nye voprosy refrakternoĭ serdechnoĭ nedostatochnosti. [Various urgent problems of refractory cardiac insufficiency]. Terapevticheskii arkhiv, 50(12), 3-10.
Mukharliamov, N M, and Mareev, V Iu. "Nekotorye aktual'nye voprosy refrakternoĭ serdechnoĭ nedostatochnosti." [Various urgent problems of refractory cardiac insufficiency]. Terapevticheskii arkhiv vol. 50,12 (1978): 3-10.
Mukharliamov NM, Mareev VIu. Nekotorye aktual'nye voprosy refrakternoĭ serdechnoĭ nedostatochnosti. [Various urgent problems of refractory cardiac insufficiency]. Ter Arkh. 1978;50(12):3-10. Russian. PMID: 741371.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries